WebDoctor Encyclopedia

Gynecologic Vulva & vagina

Bartholin gland carcinoma

Bartholin gland carcinoma is a rare vulval cancer arising in one of the glands beside the vaginal opening. It is often mistaken for a cyst or abscess, so a firm lump in a woman over 40 deserves a biopsy. Surgery with groin node checks is the main treatment.

Medically reviewed Last reviewed October 20, 2026

What is Bartholin gland carcinoma?

Bartholin gland carcinoma is a rare cancer of the vulva that starts in one of the Bartholin glands. These are two small, pea-sized glands that sit on either side of the vaginal opening. They release fluid that helps keep the vulva moist.

Most problems with these glands are benign. A Bartholin cyst forms when the duct becomes blocked, and an abscess forms when that cyst becomes infected. Both are common, especially in younger women. Cancer of the gland is uncommon, accounting for only a small share of vulval cancers, roughly 3-7% (Kostov et al., 2025).

Because the cancer can look and feel like a cyst or abscess, it is often diagnosed late. About half of cases are found at an advanced stage (Kostov et al., 2025). For this reason, doctors recommend that a new Bartholin swelling in a woman over 40, or one that keeps returning, is examined carefully and sampled.

Bartholin gland carcinoma is not a single disease. The gland contains several kinds of cell, and cancer can arise from any of them. The three main types are squamous cell carcinoma, adenoid cystic carcinoma and adenocarcinoma, and each behaves differently (Di Donato et al., 2017). Treatment usually involves surgery to remove the tumour and check the groin lymph nodes, often followed by radiotherapy.

1. Key facts at a glance

Feature Details
Type of cancer Carcinoma arising in the Bartholin gland of the vulva
How common Rare; about 3-7% of vulval cancers
Typical age Usually 40s-70s; HPV-related cases can occur younger
Main types Squamous cell carcinoma, adenoid cystic carcinoma, adenocarcinoma
Usual first sign A firm lump at the side of the vaginal opening
Common misdiagnosis Bartholin cyst or abscess
Lymph node spread In more than 40% of cases
Main treatment Wide excision, groin node assessment, often radiotherapy
Outlook Variable; worse with lymph node spread or adenocarcinoma

2. Types of Bartholin gland carcinoma

A review of 275 published cases found that squamous cell carcinoma, adenoid cystic carcinoma and adenocarcinoma each made up roughly a quarter to a third of cases (Di Donato et al., 2017).

Type Share in pooled data Key features
Squamous cell carcinoma About 31% Arises near the duct opening; may be linked to HPV
Adenoid cystic carcinoma About 30% Slow growing; spreads along nerves; late recurrences, often in the lungs
Adenocarcinoma About 25% Arises from the gland itself; linked with a poorer outlook
Other types The remainder Adenosquamous, transitional cell, small cell and other rare types

Molecular clues

Laboratory tests help confirm the type and rule out spread from another organ (Kostov et al., 2025).

Test Use
p16 or HPV testing Identifies HPV-associated squamous cell carcinoma
MYB or MYBL1 gene fusions Support adenoid cystic carcinoma
CK20, CDX2, SATB2 stains Identify intestinal-type adenocarcinoma and help exclude bowel cancer spread

Bartholin cyst, abscess or cancer?

Feature Cyst Abscess Carcinoma
Onset Gradual Quick, over days Gradual, over weeks or months
Pain Usually painless Very painful, hot, red Often painless at first
Feel Soft, smooth Tense and tender Firm, hard or fixed
Age Often under 40 Any age Usually over 40
After drainage May recur Usually settles Persists or regrows

3. Causes and risk factors

Risk factor Notes
Age over 40 Most cases occur in midlife or later
Human papillomavirus (HPV) Linked with some squamous cell carcinomas, usually in younger women
Smoking Increases the risk of HPV-related cancers
Weakened immune system Raises the risk of HPV-related disease
Previous Bartholin cysts No proven link, but recurring swellings should be checked

The cause of adenoid cystic carcinoma and adenocarcinoma of the gland is not known. Women with HPV-associated tumours tend to be younger and to do better than those with other types (Kostov et al., 2025).

4. How does it look

On examination

Feature Description
Position Low on one side of the vaginal opening, deep in the labia
Lump Firm, solid, sometimes fixed to deeper tissue
Surface Normal skin, or an ulcer in advanced cases
Size From 1 cm to several centimetres
Groin Enlarged lymph nodes in some women

On scans

Test What it shows
MRI of the pelvis Size, depth and spread to the vagina, rectum or pelvic floor
CT or PET-CT Lymph node and distant spread
Ultrasound of the groins Groin node size; may guide a needle biopsy

Under the microscope

The pathologist confirms that the cancer comes from the Bartholin gland itself, ideally by finding a transition from normal gland tissue to tumour, and excludes spread from elsewhere.

5. Symptoms

Common symptoms

  • A lump at the side of the vaginal opening
  • Discomfort or pain, especially when sitting, walking or during sex
  • A “cyst” that keeps coming back or does not go away after drainage

Less common symptoms

Symptom What it may mean
Bleeding or discharge Ulceration of the tumour
Itching or burning Irritation of the vulval skin
Lump in the groin Spread to lymph nodes
Pain spreading to the buttock or leg Nerve involvement, especially with adenoid cystic carcinoma
Bowel or urinary symptoms Advanced local spread

When to seek medical advice

See a doctor or gynaecologist if you notice a new lump near the vaginal opening, particularly if you are over 40, if it is firm and painless, or if a previously treated cyst returns. Most such lumps are benign, but they should be examined.

6. Diagnosis

Test Purpose
Pelvic and groin examination Assesses the lump and lymph nodes
Biopsy Confirms cancer and type; often needed for any solid Bartholin mass in women over 40
Excision of the gland Sometimes performed for diagnosis
MRI of the pelvis Local extent
CT or PET-CT Spread to nodes and distant organs
Groin ultrasound with needle sampling Assesses suspicious nodes
Colposcopy and cervical screening Checks for other HPV-related changes

Staging

Bartholin gland carcinoma is staged using the FIGO system for vulval cancer.

Stage General meaning
Stage I Confined to the vulva or perineum
Stage II Extends to the lower urethra, lower vagina or anus
Stage III Spread to groin lymph nodes or upper parts of nearby organs
Stage IV Fixed to bone, involves bladder or rectal lining, or distant spread

7. Treatment

Treatment should take place in a specialist gynaecological oncology centre (Ouldamer et al., 2013). Because the disease is so rare, care follows the principles used for vulval cancer, adapted to the tumour type.

Surgery

Procedure Purpose
Radical local excision Removes the tumour with a margin of healthy tissue
Radical hemivulvectomy Removes one side of the vulva for larger tumours
Sentinel lymph node biopsy Samples the first draining groin node, in selected small tumours
Inguinofemoral lymphadenectomy Removes groin nodes; often both sides are assessed
Reconstruction Skin flaps to close larger wounds

Recent guidance stresses complete removal with clear margins and assessment of the groin nodes on both sides (Kostov et al., 2025).

Radiotherapy

Situation Role
Close or positive margins Lowers local recurrence
Positive lymph nodes Treats the groins and pelvis
Adenoid cystic carcinoma Often advised because of spread along nerves
Tumours that cannot be removed Chemoradiotherapy as main treatment

In an early series of 36 patients, local recurrence was much less frequent in women who received radiotherapy than in those who did not (Copeland et al., 1986).

Chemotherapy and newer drugs

Treatment Use
Cisplatin with radiotherapy (chemoradiotherapy) Advanced squamous cell carcinoma
Platinum-based chemotherapy Spread to distant organs
Immune checkpoint inhibitors Emerging evidence in squamous tumours
Targeted drugs Being explored in adenocarcinoma, guided by molecular tests

Side effects

Treatment Possible side effects
Vulval surgery Wound breakdown, infection, change in appearance, pain during sex
Groin node surgery Leg swelling (lymphoedema), fluid collections, numbness
Radiotherapy Skin soreness, vaginal dryness and narrowing, bowel and bladder irritation
Chemotherapy Tiredness, nausea, low blood counts

What treatment involves day to day

Stage What to expect
Surgery Usually 2-7 days in hospital, depending on the extent
Wound healing Several weeks; careful hygiene and dressings
Radiotherapy Weekday sessions for about 5-6 weeks
Recovery of sexual function Gradual; vaginal dilators and lubricants help

8. Outlook (prognosis)

Factor Effect on outlook
Lymph node involvement The strongest predictor of worse survival
Adenocarcinoma type Poorer outlook than other types
HPV-associated squamous carcinoma Generally better outlook
Adenoid cystic carcinoma Good early survival, but late recurrences and lung spread
Clear margins and radiotherapy where needed Lower risk of local recurrence
Advanced stage at diagnosis Poorer outlook

In pooled data, adenocarcinoma and positive lymph nodes were both linked with poorer survival (Di Donato et al., 2017). In the series by Copeland and colleagues, about five in six women were alive at five years after combined treatment (Copeland et al., 1986).

Lessons from a 30-year hospital series

One of the largest single-centre reports described 36 women treated over three decades (Copeland et al., 1986).

Finding Result
Most common type Squamous cell carcinoma (27 of 36)
Stage spread Most women had stage I or II disease
Nodes involved when removed 14 of 30 women (47%)
Recurrences 9 women, mostly in the vulva
Local recurrence with radiotherapy 1 of 14 (7%)
Local recurrence without radiotherapy 6 of 22 (27%)
Five-year survival 84%

The authors concluded that wide excision, removal of the groin nodes on the affected side and added radiotherapy gave very good results. Modern practice now favours checking both groins (Kostov et al., 2025).

Why the evidence is limited

There have been no randomised trials in this disease, so treatment advice comes from case series, pooled reviews and vulval cancer guidelines (Ouldamer et al., 2013). Experts call for referral to specialist centres and international collaboration so that larger studies become possible (Di Donato et al., 2017).

9. Follow-up

Follow-up Purpose
Examination every 3-6 months for 2-3 years Checks the vulva and groins
Then every 6-12 months up to 5 years Continued monitoring
Long-term follow-up for adenoid cystic carcinoma Recurrences can occur many years later
Chest imaging Particularly for adenoid cystic carcinoma
Cervical screening Continue as advised

10. Living with Bartholin gland carcinoma

  • Keep the wound clean and dry while healing, and report redness or discharge
  • Wear compression stockings and do leg exercises if you develop lymphoedema
  • Use vaginal dilators after radiotherapy if advised, to prevent narrowing
  • Talk openly about sex and intimacy; specialist nurses and psychosexual counsellors can help
  • Stop smoking, especially with HPV-related cancer
  • Report new lumps, bleeding or leg swelling promptly
  • Seek support from gynaecological cancer charities

11. Frequently asked questions

Question Answer
Is a Bartholin cyst cancer? Almost never; cysts and abscesses are common and benign
Why was my cancer first treated as a cyst? The two can look and feel alike, which is why persistent lumps need a biopsy
Is it caused by HPV? Some squamous cell carcinomas are; other types are not
Will I need groin surgery? Usually the groin nodes are assessed, by sentinel node biopsy or dissection
Will sex be possible afterwards? For many women yes, with time and support
Can it come back? Yes, so regular follow-up is important
Is it inherited? No
Why do I need a specialist centre? The disease is rare, and experienced teams achieve better surgical results
Will I need a stoma? Rarely; only if the bowel is involved in advanced disease

12. Questions to ask your care team

  • Which type of Bartholin gland carcinoma do I have?
  • What stage is it, and are my lymph nodes involved?
  • What operation do you recommend, and will both groins be checked?
  • Will I need radiotherapy or chemotherapy?
  • How will treatment affect my sexual function and continence?
  • What follow-up will I need, and for how long?

Resources

  1. Copeland, L.J. et al. (1986) ‘Bartholin gland carcinoma’, Obstetrics and Gynecology, 67(6), pp. 794-801.
  2. Di Donato, V. et al. (2017) ‘Bartholin gland cancer’, Critical Reviews in Oncology/Hematology, 117, pp. 1-11.
  3. Kostov, S. et al. (2025) ‘Bartholin gland carcinoma: a state-of-the-art review of epidemiology, histopathology, molecular testing, and clinical management’, Cancers, 17(23), 3819.
  4. Ouldamer, L. et al. (2013) ‘Bartholin’s gland carcinoma: epidemiology and therapeutic management’, Surgical Oncology, 22(2), pp. 117-122.
  5. National Cancer Institute (2026) Vulvar Cancer Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/vulvar/hp/vulvar-treatment-pdq (Accessed: October 2026).

Prepared by the editorial team, October 2026.